Horizon Therapeutics (NASDAQ: HZNP)
Horizon Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Horizon Therapeutics Company Info
Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.
News & Analysis
Why Horizon Therapeutics Stock Is Crashing Today
The FTC is reportedly gearing up to block the drugmaker's takeover by Amgen.
Why Horizon Therapeutics Stock Is Soaring Today
Amgen's planned acquisition of Horizon could close in the first half of next year.
Why Horizon Therapeutics Stock Is Skyrocketing Today
Three big drugmakers could be interested in acquiring Horizon.
Why Horizon Therapeutics' Shares Rose 11.32% on Wednesday
The company released encouraging year-end guidance.
This Therapeutics Company Is Eyeing Zero Competition for the Next 5 Years
If production setbacks can be avoided, gains should be in sight.
3 Reasons to Buy Horizon Therapeutics Stock and 1 Not To
Horizon Therapeutics's shares are up almost 200% over the past 12 months, buoyed by mind-boggling sales of its new blockbuster drug.
Does 2021's Best Biopharma to Work for Belong in Your Portfolio?
Horizon Therapeutics has a clear path to significant sales growth.
Why Horizon Therapeutics Stock Jumped Today
The biopharmaceutical company released its latest quarterly update.
Valuation
Earnings Transcripts
Horizon Pharma plc (HZNP) Q3 2021 Earnings Call Transcript
HZNP earnings call for the period ending September 30, 2021.
Horizon Therapeutics PLC (HZNP) Q2 2021 Earnings Call Transcript
HZNP earnings call for the period ending June 30, 2021.
Horizon Therapeutics PLC (HZNP) Q1 2021 Earnings Call Transcript
HZNP earnings call for the period ending March 31, 2021.
Horizon Therapeutics PLC (HZNP) Q4 2020 Earnings Call Transcript
HZNP earnings call for the period ending December 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.